EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Refinement of newborn screening for cystic fibrosis with next generation sequencing

Michael J Rock iD, Mei Baker, Nicholas Antos iD, Philip M Farrell iD

Pediatric Pulmonology · 2023-03 · 58 (3) · 778-787

DOI: 10.1002/ppul.26253 ↗

At a glance

Journal article in Pediatric Pulmonology, published online on 2022-12-05. Written by Michael J Rock and 3 co-authors. Institution: Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Major MEDLINE topics: Cystic Fibrosis. Cited 33 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Legacy of Angels Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Newborn screening for cystic fibrosis (CF) has been underway universally in the United States for more than a decade, as well in most European countries, and algorithms have been evolving throughout this period with quality improvement projects as immunoreactive trypsinogen (IRT) determinations alone have been transformed to a 2‐tier strategy with DNA analyses.

Objective

To apply next generation sequencing (NGS) as a screening method to expand the DNA tier and identify substantially more variants in the CF transmembrane conductance regulator ( CFTR ) gene to enhance sensitivity and equity while minimizing incidental findings.

Design

Sequential evaluation and improvement plan in three phases using algorithm modifications coupled to statewide follow up and analysis of screening outcomes.

Results

After demonstrating feasibility in the first phase, we studied an IRT/NGS algorithm that included CFTR Variants with Varying Clinical Consequences (VVCCs). This revealed a high identification of CF patients with 2‐variants detected through screening, but for every CF case there were 1.4 with CF metabolic syndrome/CF screen positive, inconclusive diagnosis (CRMS/CFSPID). This led us to a third phase of improvement in which the VVCCs were eliminated except for R117H, resulting in 94% 2‐variant detection of patients and 0.44:1 ratio of CRMS/CFSPID to CF.

Conclusion

NGS can be used with IRT as an effective method of identifying infants at risk for CF without an appreciable increase in detection of carriers. Its potential added value includes facilitating equity, enhancing sensitivity and detecting more CF patients with 2‐variants during the screening process.

Subjects

MeSH terms (MEDLINE)

Cystic FibrosisInfantInfant, NewbornHumansCystic Fibrosis Transmembrane Conductance RegulatorNeonatal ScreeningHigh-Throughput Nucleotide SequencingHeterozygoteTrypsinogenMutation

Author keywords

cystic fibrosiscystic fibrosis transmembrane conductance regulator geneimmunoreactive trysinogennewborn screeningnext generation sequencing

Substances

Cystic Fibrosis Transmembrane Conductance RegulatorTrypsinogen

Authors and institutions

  • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Newborn Screening Laboratory, Wisconsin State Laboratory of Hygiene, University of Wisconsin school of Medicine and Public Health, Madison, Wisconsin, USA.
  • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

ORCID profiles: Michael J Rock, Nicholas Antos, Philip M Farrell

Funding

  • Legacy of Angels Foundation

Cite

APA

Rock, M. J., Baker, M., Antos, N., & Farrell, P. M. (2023). Refinement of newborn screening for cystic fibrosis with next generation sequencing. Pediatric Pulmonology, 58(3), 778-787. https://doi.org/10.1002/ppul.26253

Vancouver

Rock MJ, Baker M, Antos N, Farrell PM. Refinement of newborn screening for cystic fibrosis with next generation sequencing. Pediatric Pulmonology. 2023;58(3):778-787. doi:10.1002/ppul.26253

BibTeX
@article{Rock2023,
  author = {Rock, Michael J and Baker, Mei and Antos, Nicholas and Farrell, Philip M},
  title = {Refinement of newborn screening for cystic fibrosis with next generation sequencing},
  journal = {Pediatric Pulmonology},
  year = {2023},
  volume = {58},
  number = {3},
  pages = {778--787},
  doi = {10.1002/ppul.26253}
}
Start for free →